What Researchers Did
The researchers combined the results of randomized controlled trials to see whether hyperbaric oxygen therapy, used as an added treatment, helped newborns with brain injury from low oxygen and blood flow (hypoxic-ischemic encephalopathy).
What They Found
This meta-analysis of 46 randomized controlled trials including 4,199 newborns with hypoxic-ischemic encephalopathy found that hyperbaric oxygen therapy was linked to better total treatment efficiency, with an odds ratio of 4.61 (95% confidence interval 3.70 to 5.75, p less than 0.00001). The analysis also reported a lower risk of sequelae (odds ratio 0.23, 95% confidence interval 0.16 to 0.33, p less than 0.00001). Neonatal behavioral neurological assessment scores differed by a mean of 4.51 points (95% confidence interval 3.83 to 5.19, p less than 0.00001). The authors concluded that hyperbaric oxygen therapy can be a potential therapy for this condition.
What This Means for Canadian Patients
For families of newborns with hypoxic-ischemic encephalopathy, this analysis suggests hyperbaric oxygen therapy is a potential treatment, not a proven one. The authors say more research is needed before the therapy can be widely used in the clinic. Treatment decisions for a newborn should be made with the neonatal care team.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The studies used different protocols and patient selection, and all the patients came from China, so the authors say the findings may not apply widely and more research is needed before the therapy can be widely used in the clinic.